INTRODUCTION
In order to interrogate the catalytic properties of the P450 under investigation, the majority of studies performed in reconstituted systems are generally conducted using saturating, or nearly saturating concentrations of CPR; however, in the endoplasmic reticulum (ER), P450s exist in vast excess (up to 20 fold) over CPR (Estabrook et al., 1971) . Despite the plethora of Chemicals. All chemicals used are of ACS grade unless otherwise specified and were obtained from commercial vendors. Benzphetamine (BNZ), p-nitrophenol (p-NP), NADPH, sodium dithionite, ascorbic acid and tert-butyl hydroperoxide were purchased from Sigma.
Trifluoroacetic acid was purchased from Pierce Chemicals (Rockford, IL).
Dilauroylphosphatidylcholine (DLPC) was purchased from Doosan Serdary Research Laboratory (Toronto, Canada). Carbon monoxide gas (purity >99.5%) was purchased from Cryogenic Gases (Detroit, MI).
Construction of CYP2E1 Y422D variant. Site-directed mutagenesis was performed using a
QuikChange site-directed mutagenesis kit according to the manufacturer's protocol (Stratagene).
The forward and reverse mutagenic primers for Y422D were GGAAAGTTCAAGGACAGTGACTATTTCAAGCC and GGCTTGAAATAGTCACTGTCCT TGAACTTTCC, respectively. DNA sequencing performed at the University of Michigan DNA Sequencing Core confirmed the desired site-specific mutation.
Overexpression and Purification of Enzymes. The plasmids for the N-terminal truncated and
C-terminal His-tagged CYP2B4dH (hereon referred to as CYP2B4) and human CYP2E1 were a generous gift from Dr. James Halpert. These two P450s and the CYP2E1 Y422D variant were over-expressed in Escherichia coli C41 (DE3) cells separately and purified using a Ni-NTA affinity column as described previously (Scott et al., 2003; Pratt-Hyatt et al., 2010) . The concentrations of CYP2B4 and CYP2E1 were determined using an extinction coefficient of
8 extinction coefficient of 21 mM -1 cm -1 at 456 nm for the oxidized enzyme (Vermilion and Coon, 1978) .
Determination of the Inhibition of CYP2B4-Mediated N-demethylation of BNZ by CYP2E1
WT and the CYP2E1 Y422D Variant. The extent to which varying concentrations of either CYP2E1 WT or CYP2E1 Y422D inhibited the rate of formaldehyde formation by CYP2B4 (0.25 µM) was assessed at 37 o C using a fixed concentration of CPR and BNZ. CYP2B4 was reconstituted in triplicate with increasing concentrations of CYP2E1 WT or CYP2E1 Y422D
(0.25, 0.5, 0.75, 1.0, 1.25, 1.50 µM), CPR (0.5 μM) and 0.03 mg/ml DLPC on ice for 1 h. The reconstituted mixtures were then added to 50 mM potassium phosphate buffer, pH 7.4, and BNZ (1.2 mM). After the samples were equilibrated at 37 o C for 15 min, the reactions were initiated by adding 7.5 µL of 20 mM NADPH to give a final reaction volume of 500 µL. The reactions were incubated for 5 min at 37 o C and then quenched by the addition of 25 µL of 50% TFA. The proteins were precipitated by centrifugation at 13.2k rpm in an Eppendorf 5415D microcentrifuge for 5 min and a 500 µL aliquot of the supernatant was assayed for formaldehyde using the Nash reaction (Nash, 1953) . concentration with increasing concentrations of CPR as previously described (Kenaan et al., 2011) . Briefly, CYP2B4 WT (0.25 µM) was reconstituted in triplicate with varying concentrations of CPR (0.1, 0.2, 0.3, 0.6, 0.8, 1.2 and 1.4 µM) and 0.03 mg/ml DLPC on ice for 1 h. The reconstituted mixtures were then added to 50 mM potassium phosphate buffer, pH 7.4, containing 1.2 mM BNZ. After the samples were equilibrated at 37 o C for 15 min, the reactions were initiated by adding 7.5 µL of 20 mM NADPH to give a final reaction volume of 500 µL.
The reactions were incubated for 5 min at 37 o C and then quenched by the addition of 25 µL of 50% TFA. The proteins were precipitated by centrifugation at 13.2k rpm in an Eppendorf 5415D microcentrifuge for 5 min and a 500 µL aliquot of the supernatant was assayed for formaldehyde using the Nash reaction. The kinetic parameters were determined by fitting the data to the Michaelis-Menten equation using GraphPad Prism 5.0 from GraphPad software (La Jolla, CA).
The free concentrations of CPR in the plot were calculated from the initial concentration of CPR and the apparent K m . To determine the effect of CYP2E1 on the apparent K M and k cat of the 0.2, 0.4, 0.6, 0.8 mM) . After the samples were equilibrated at 37 o C for 15 min, the reactions were initiated by adding 7.5 µL of 20 mM NADPH to give a final reaction volume of 500 µL.
The reactions were incubated for 5 min at 37 o C and then quenched by the addition of 25 µL of 50% TFA. The protein was precipitated by centrifugation at 13.2k rpm in an Eppendorf 5415D microcentrifuge for 5 min and a 500 µL aliquot of the supernatant was assayed for formaldehyde using the Nash reaction. To determine whether the original K M value in the absence of CYP2E1 could be observed by using saturating concentrations of CPR, this experiment was repeated in the presence of 2.5 µM CPR. The kinetic parameters were determined by fitting the data to the Michaelis-Menten equation using GraphPad Prism 5.0.
Spectral Dissociation Constant (K s ) for the Binding of BNZ to CYP2B4 in the Presence and
Absence of CYP2E1. BNZ binding to ferric CYP2B4 was monitored spectrophotometrically as previously described by measuring the type I spectral changes (Zhang et al., 2009) . Briefly, 1 µM of CYP2B4 and 0.1 mg/ml DLPC were reconstituted in the presence or absence of 4 µM CYP2E1 on ice for 1 hr. Equal volume of the reconstitutions were then aliquoted to solutions containing 0.1 M potassium phosphate (pH 7.4) and 0.1 mg/ml DLPC and were added to the sample and reference cuvettes in a UV-2501PC spectrophotometer (Shimadzu Corporation, Kyoto, Japan). A baseline was recorded after thermal equilibration at 30 o C for 5 min. CYP2B4 in the sample cuvette was titrated with aliquots of 20 mM BNZ while an equal volume of water was added to the reference cuvette. The difference spectra were recorded from 350-500 nm and the were then added to 50 mM potassium phosphate buffer, pH 7.4, containing 0.3 mM p-NP and 2 mM ascorbic acid. After the samples were equilibrated at 37 o C for 15 min, the reactions were initiated by adding 20 μL of 20 mM NADPH to give a final reaction volume of 1000 μL. The reactions were incubated for 20 min at 37 o C before they were quenched with 300 μL 20% TCA.
The samples were then incubated on ice for 10 min and centrifuged at 13.2k rpm in an Eppendorf 5415D microcentrifuge for 5 min. The absorbance at 510 nm was then measured by transferring a 1000 μL aliquot of the reaction mixture to a cuvette containing 100 μL of 10 M NaOH. The kinetic parameters were determined by fitting the data to the Michaelis-Menten equation using GraphPad Prism 5.0 from GraphPad software (La Jolla, CA). The free concentrations of CPR in the plot were calculated from the initial concentration of CPR and the apparent K m . Figure 1A illustrate that increasing concentrations of CYP2E1 can inhibit the activity of CYP2B4 up to approximately 80% of the activity observed in the absence of CYP2E1. The data also show that the inhibition can be fit to a rectangular hyperbolic function and follows saturation kinetics. In order to determine whether the decrease in the CYP2B4 catalytic activity is due to a disruption of the interaction between CYP2B4 and CPR or to direct interaction between CYP2B4 and CYP2E1, the metabolism of BNZ by CYP2B4 supported by tBHP was determined in the presence of increasing concentrations of CYP2E1. Although the presence of CYP2E1 significantly decreased the metabolism of BNZ by CYP2B4 when supported by CPR, CYP2E1
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had virtually no effect on BNZ metabolism by CYP2B4 when supported by tBHP. Since hydroperoxides and other artificial oxygen donors are able to support substrate metabolism by
P450s in the absence of redox partners such as CPR, the decrease in the CPR-supported BNZ activity with no change in the tBHP-supported activity suggests that inhibition is not due to direct CYP2B4-CYP2E1 interactions but rather due to an effect on CPR-CYP2B4 interaction.
The ability of CYP2B4 to inhibit or stimulate the metabolism of p-NP by CYP2E1 was also investigated and the results shown in Figure 1B demonstrate that CYP2B4 does not have any significant effect on the catalytic activity of CYP2E1. Therefore, the inhibition observed in the reconstituted system is solely by an effect of CYP2E1 on CYP2B4, which is not reciprocated.
Inhibition of CYP2B4 activity by the CYP2E1 Y422D variant -Previous studies by Lin et al.
( Lin et al., 2007) led us to express and purify the CYP2E1 Y422D mutant in order to dissect out whether the inhibitory phenomenon observed in Figure 1 A was due to the CYP2E1 -CPR interaction. The Y422 residue of CYP2E1 can be nitrated by peroxynitrite and its modification results in a loss in the CPR-supported CYP2E1 activity when compared to tBHP-supported activity (Lin et al., 2007) . Since the FMN domain of CPR, which is highly negatively charged, is believed to interact with the proximal side of CYP2E1, we hypothesized that replacing Tyr 422
with Asp using site-directed mutagenesis would create a charge repulsive interaction between the CYP2E1 Y422D and its residue counterpart in CPR that would perturb the apparent affinity of the two proteins for each other. Using stopped-flow studies we have previously shown that the extent of reduced CO-complex formation upon addition of NADPH is an indicator of the extent of P450-CPR complex and thus, it reflects the affinity of the P450 under investigation for CPR (Kenaan et al., 2011) . The extent of reduction of the CYP2E1 Y422D mutant by CPR and NADPH relative to the reduction of WT CYP2E1 by CPR and NADPH can be determined by measuring the absorbance of the Y422D-CO complex at 450 nm and comparing this to the absorbance of the WT-CO complex at the same wavelength. As shown in Figure 2A , the interaction of CYP2E1 Y422D with CPR decreases by 50% compared to WT. Furthermore, the
15 apparent K M value of this variant for CPR increased significantly as a result of mutagenesis (data not shown). Interestingly, when the inhibitory potential of this mutant for CYP2B4 was investigated, the results showed that it inhibited CYP2B4 activity to a significantly lesser extent than the WT CYP2E1 ( Figure 2B ). concentrations it was observed that this data could be divided into two sets ( Figure 4 ). These data sets were grouped based on whether the linear regression analysis resulted in an intersection at a common value on the y-axis but diverged on the x-axis or whether the lines diverged on the yaxis and intersected on the x-axis. The data shown in Figure 4A clearly demonstrate that between 0 -0.75 μM CYP2E1 the apparent K M values change significantly while the k cat values remain almost unchanged. This is indicative of a competitive interaction. Figure 4B illustrates the noncompetitive nature of CYP2E1 inhibition as the apparent K M values for 1.25 and 1.50 μM CYP2E1 are relatively similar to the apparent K M value observed in the absence of CYP2E1, yet the k cat decreases significantly as evidenced by an increase in the y-intercept value compared to 0 μM CYP2E1. Therefore under our experimental conditions it appears that CYP2E1 inhibits the formation of the CYP2B4-CPR complex by acting as a competitive inhibitor at low concentrations and as a noncompetitive inhibitor at higher concentrations.
Determination
To estimate a K i for CYP2E1 as a competitive inhibitor of the CYP2B4-CPR complex we plotted the K M obs as a function of CYP2E1 concentration (Kakkar et al., 1999) . These data were fit to a straight line that intersected the x-axis at an absolute value of 0.02 μM ( Figure 5 ).
Therefore CYP2E1 is a potent CYP2B4 inhibitor with a nanomolar affinity. Global non-linear analysis of CYP2E1 concentrations 0 -1.50 μM by GraphPad Prism revealed a K i of 0.038 μM.
Steady-state activity of CYP2B4 for the Metabolism of BNZ in the Presence and Absence of
CYP2E1 -Previous reports have suggested an interplay between redox partner affinity and substrate affinity for P450s (French et al., 1980; Bonfils et al., 1981) . Since the binding affinity of BNZ to CYP2B4 may be enhanced by the interaction between CYP2B4 and CPR (and vice-
17 versa) we hypothesized that a perturbation in the formation of the CYP2B4-CPR complex by CYP2E1 might lead to changes in the kinetic parameters of CYP2B4 for BNZ. The K M and k cat of CYP2B4 for BNZ were determined initially by varying the concentrations of BNZ in the reaction mixture while keeping the concentrations of CYP2B4 and CPR constant and equal. This was then repeated in the presence of a four-fold excess in the concentration of CYP2E1 over CYP2B4. The data in Figure 6 and Table 2 Table 2 ). Therefore, we hypothesized that an alternative mechanism of inhibition may account for this difference. Since the previous studies on the inhibition of CYP2B4 by CYP2E1
were performed in the presence of excess BNZ (1.2 mM), a perturbation in the affinity of CYP2B4 for BNZ by CYP2E1 may have eluded our detection in these studies. BNZ induces a type I spectral shift upon binding to CYP2B4 but not CYP2E1 (data not shown) and this can be exploited to determine the effect of CYP2E1 on the affinity of CYP2B4 for its substrate. The results in Figure 7 show that BNZ binds to CYP2B4 with a K s of 11.4 μM and that in the presence of CYP2E1 this increases by approximately 30 fold to 339 μM. Thus, CYP2E1 not only inhibits complex formation between CYP2B4 and CPR but also affects complex formation between CYP2B4 and BNZ ( Figure 7 ).
Determination of the apparent K M and k cat Values for the Interactions of CYP2E1 WT with
CPR -The ability of CYP2E1 to out-compete CYP2B4 for CPR could be attributed to a higher affinity (lower K M ) of CYP2E1 for CPR compared to CYP2B4 for CPR. However, our results
show that CYP2E1 and CYP2B4 have similar affinities for CPR with apparent K M values of 0.14 μM and 0.08 μM, respectively (Tables 1 and 3) . Interestingly, when the apparent K M of CYP2E1
for CPR was measured in the presence of CYP2B4 we observed a 68% decrease in the apparent K M and an increase in the k cat ( Figure 8 and Table 3 ). The final apparent K M value, 0.04 μM, is close to the K i of CYP2E1 for the CYP2B4 -CPR complex, which is 0.02 μM determined in 
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For almost four decades it has been known that P450's exist in significant excess (~ 20 fold) over CPR yet very little is known about their spatial distribution within the membrane (Estabrook et al., 1971) . Even less is known about how the disparity in the molar ratio of P450s to CPR influences the catalytic activities of the various isoforms of the P450s and whether this impacts the pharmacokinetic profile of drugs that mainly undergo metabolism by specific P450s.
The objective of this study was to assess the effect of varying amounts of CYP2E1, CYP2B4 and CPR on P450 catalytic activity with the ultimate goal of using this information to improve our understanding of the effect on P450-P450 interaction on drug metabolism in humans.
The ability of peroxides and hydroperoxides to bypass the need for the delivery of two electrons from CPR makes tBHP a useful experimental tool to study the catalytic properties of the P450 heme in the absence of CPR. In order to differentiate direct P450-P450 interactions from P450-CPR interactions that lead to inhibition, we measured CYP2B4 activity supported by CPR and tBHP. The data show that CYP2B4 was resistant to inhibition by CYP2E1 when BNZ metabolism was supported by tBHP, but lost up to 80% of its BNZ demethylase activity when supported by NADPH and CPR. This suggests that competition for CPR is implicated in the inhibitory phenomenon observed in Figure 1A . To further interrogate the contribution of the CYP2E1 -CPR interaction to the inhibition of CYP2B4 we investigated whether a CYP2E1 variant (Y422D), which has a mutation in the proximal side that reduces its binding to CPR by approximately 50%, could alter the extent of inhibition of CYP2B4 activity by CYP2E1. Our results show that the extent of CYP2B4 inhibition by CYP2E1 Y422D is significantly less than that observed with the WT CYP2E1 suggesting a role for the CYP2E1-CPR interaction in the inhibition of CYP2B4 activity supported by CPR.
The notion that CYP2E1 perturbs the formation of the CYP2B4-CPR complex is further supported by the data on the effect of CYP2E1 on the apparent K M of CYP2B4 for CPR, which In order to propose a tentative model to explain our kinetic data we took into account the following findings: 1) direct CYP2B4-CYP2E1 interactions alone do not lead to inhibition of CYP2B4 activity in the presence of saturating concentrations of BNZ ( Figure 1A ), 2) CYP2B4
and CYP2E1 interact directly to reduce the affinity of CYP2B4 for BNZ ( Figure 7 ) and 3)
CYP2E1 has a higher affinity for CPR in the presence of CYP2B4 (Figure 8 ). In light of these findings, one possible mechanism that may explain the inhibitory behavior of CYP2E1 toward CYP2B4 is depicted in Figure 9 . In this model, CYP2E1 and CYP2B4 interact to form a interactions between CYP1A2 and CYP2E1 lead to significantly enhanced rates of 7-ethoxyresorufin (7-ER) and 7-pentoxyresorufin (7-PR). However, when interactions between CYP2E1 and CYP2B4 were investigated using 7-ER, 7-PR and aniline as substrates, functional interactions between these two P450s were not observed suggesting that they did not form P450-P450 complexes. Or, it is possible that complex formation had no effect on any of the activities measured. Therefore, the differences between our results and those of Kelly et al. may be due to differences in the substrates used, as previous work has shown that interactions between P450s are highly dependent on the substrates under investigation (Cawley et al., 1995) . Since Cawley et al. used full-length CYP2B4 and CYP2E1, it is also possible that N-terminal truncation of CYP2B4 and CYP2E1 employed in the present study may account for the observed differences.
A significant amount of effort is expended by pharmaceutical and pharmacokinetic modeling companies to predict in vivo pharmacokinetic profiles of drugs from in vitro data (Rostami-Hodjegan and Tucker, 2007) . Since protein-protein interactions in the P450 system may confound in vitro -in vivo drug metabolism extrapolations, it is important that in depth kinetic studies be conducted to determine the kinetic basis and associated kinetic constants that govern these interactions. The information obtained from these types of studies is invaluable as it can play an important role in improving our ability to predict in vivo drug clearance and drugdrug interactions from in vitro data.
To assess the biological relevance of the findings reported in the present study, it would be of interest to investigate the possibility of in vivo interactions between CYP2E1 and CYP2B4 in rabbit. For example, if either concomitant or chronic administration of ethanol (a CYP2E1 Table 2 . The effect of CYP2E1 and CPR on the apparent K M and k cat of CYP2B4 for the metabolism of BNZ. The rate of BNZ N-demethylation by CYP2B4 was determined as described in Materials and Methods. All samples contained 0.50 μM CYP2B4 and increasing concentrations of BNZ. The "control" sample contained equal concentrations of CPR and CYP2B4, "plus CYP2E1" contained 2 μM CYP2E1 in addition to the components in the "control" sample, "plus CYP2E1 and excess CPR" contained 2.5 μM CPR in addition to the components in the "plus CYP2E1" sample and, "plus excess CPR" contained the same components as the "control" sample except for the addition of 2.5 μM CPR. The kinetic values given here were derived from data plotted in Figure 6 . 
CYP2B4
Control
